Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Barreiro

Showing results (171-180 of 220) with videos related to

Pageof 22
Sort By:
AIDS (London, England)|March 19, 2014
Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapyEugenia Vispo, Pablo Barreiro, Zulema Plaza, et al.
AIDS (London, England)|March 20, 2010
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrationsSonia Rodríguez-Nóvoa, Pablo Labarga, Antonio D'avolio, et al.
AIDS (London, England)|February 23, 2007
Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapyCarmen de Mendoza, Luz Martin-Carbonero, Pablo Barreiro, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 7, 2023
Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in SpainJosé Manuel Ramos-Rincon, Héctor Pinargote-Celorio, Carmen de Mendoza, et al.
Antiviral Therapy|May 7, 2013
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevirJosé M Benito, Clara Sánchez-Parra, Ivana Maida, et al.
Antiviral Therapy|May 12, 2009
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammationEugenia Vispo, Pablo Barreiro, José Del Valle, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 18, 2009
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcomeDavid Townsend, Jesús Troya, Ivana Maida, et al.
AIDS (London, England)|March 6, 2009
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovirPablo Labarga, Pablo Barreiro, Luz Martin-Carbonero, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2006
Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapyPablo Barreiro, Jorge del Romero, Manuel Leal, et al.
AIDS (London, England)|May 15, 2013
Influence of HIV infection on response to tenofovir in patients with chronic hepatitis BZulema Plaza, Antonio Aguilera, Alvaro Mena, et al.
Pageof 22

Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
AIDS (London, England)|March 19, 2014
Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapyEugenia Vispo, Pablo Barreiro, Zulema Plaza, et al.
AIDS (London, England)|March 20, 2010
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrationsSonia Rodríguez-Nóvoa, Pablo Labarga, Antonio D'avolio, et al.
AIDS (London, England)|February 23, 2007
Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapyCarmen de Mendoza, Luz Martin-Carbonero, Pablo Barreiro, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 7, 2023
Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in SpainJosé Manuel Ramos-Rincon, Héctor Pinargote-Celorio, Carmen de Mendoza, et al.
Antiviral Therapy|May 7, 2013
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevirJosé M Benito, Clara Sánchez-Parra, Ivana Maida, et al.
Antiviral Therapy|May 12, 2009
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammationEugenia Vispo, Pablo Barreiro, José Del Valle, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 18, 2009
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcomeDavid Townsend, Jesús Troya, Ivana Maida, et al.
AIDS (London, England)|March 6, 2009
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovirPablo Labarga, Pablo Barreiro, Luz Martin-Carbonero, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2006
Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapyPablo Barreiro, Jorge del Romero, Manuel Leal, et al.
AIDS (London, England)|May 15, 2013
Influence of HIV infection on response to tenofovir in patients with chronic hepatitis BZulema Plaza, Antonio Aguilera, Alvaro Mena, et al.
Pageof 22